Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Russia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20112
20122
20132
20143
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Meshalkin Research Institute of Pathology of Circulation3
Amarin Pharma Inc.1
Bayer1
CSL Behring1
Cardium Therapeutics1
Gilead Sciences1
Janssen Research & Development, LLC1
Resverlogix Corp1
Russian Cardiology Research and Production Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease14
Angina Pectoris4
Heart Diseases4
Acute Coronary Syndrome3
Cardiovascular Diseases3
Myocardial Infarction3
Stroke3
Atherosclerosis2
Atrial Fibrillation2
Chest Pain2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.